- Conditions
- Total Parenteral Nutrition-induced Cholestasis
- Interventions
- Omegaven IV lipid emulsion
- Drug
- Lead sponsor
- Sivan Kinberg
- Other
- Eligibility
- 2 Months to 18 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2019
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–30
of 6
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Parenteral Nutrition-Associated Liver Disease
- Interventions
- Intravenous fat emulsion, Restriction of intravenous fat emulsion to 1 gm/kg/d
- Other
- Lead sponsor
- Yale University
- Other
- Eligibility
- 12 Hours to 48 Hours
- Enrollment
- 136 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Parenteral Nutrition Associated Liver Disease
- Interventions
- Omegaven
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- Up to 24 Months
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2019
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Parenteral Nutrition-Associated Liver Disease
- Interventions
- Omegaven
- Drug
- Lead sponsor
- Cook Children's Health Care System
- Other
- Eligibility
- 4 Weeks to 5 Years
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Essential Fatty Acid Deficiency (EFAD)
- Interventions
- Clinolipid, Intralipid
- Drug
- Lead sponsor
- Baxter Healthcare Corporation
- Industry
- Eligibility
- 0 Years to 17 Years
- Enrollment
- 101 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 9
- States / cities
- Mobile, Alabama • New Haven, Connecticut • Orlando, Florida + 6 more
- Conditions
- Cholestasis of Parenteral Nutrition
- Interventions
- Omegaven 10%
- Drug
- Lead sponsor
- Georgetown University
- Other
- Eligibility
- 2 Months to 18 Years
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia